August 2 2020 CBPP Spotlight

Agulnik Assesses Treatments for Basal Cell Carcinoma

September 04, 2020

Mark Agulnik, MD, discussed the guidelines and data supporting possible treatment decisions for an 88-year-old male patients with basal cell carcinoma, during a virtual Case Based Peer Perspectives event.

Spira Analyzes the Use of Durvalumab in Unresectable Stage III NSCLC

September 07, 2020

Clinical Articles

Alex Spira, MD, PhD, director, Virginia Cancer Specialists, Phase I Trial Program, Fairfax, VA, discussed the use of durvalumab as treatment of a 63-year-old male with unresectable stage III non–small cell lung cancer.

Kris Details Use of Immunotherapies After Lung Cancer Progression

September 04, 2020

During a virtual Case Based Peer Perspectives event, Mark G. Kris, MD, attending physician, Thoracic Oncology Service, William and Joy Ruane chair in Thoracic Oncology, Memorial Sloan Kettering Cancer Center, discussed molecular testing for a 59-year-old patient with poorly differentiated adenocarcinoma of the lung, as wells as the treatment options for the patient.

Johnson Examines Osimertinib in the Frontline Setting for NSCLC

September 05, 2020

Clinical Articles

The case of a 73-year-old Asian patient diagnosed with non–small cell lung cancer and an EGFR exon 19 deletion was discussed during a virtual Case Based Peer Perspectives event, led by Melissa L. Johnson, MD.